These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12906339)

  • 41. In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs.
    Wang Z; Hirayama F; Uekama K
    J Pharm Pharmacol; 1994 Jun; 46(6):505-7. PubMed ID: 7932048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preparation of nifidipine pulsatile release tablets].
    Zhang Y; Zhang ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):261-3. PubMed ID: 15071935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.
    Rani M; Mishra B
    AAPS PharmSciTech; 2004 Aug; 5(4):e71. PubMed ID: 15760068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant.
    Zhang X; Wang M; Li P; Wang A; Liang R; Gai Y; Liu W; Li Y; Sun K
    Pharm Dev Technol; 2016 Dec; 21(8):1006-1014. PubMed ID: 26446857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on oral sustained-release microspheres of nifedipine].
    Fu CD; Jiang XT; Hu JH; Wu W
    Yao Xue Xue Bao; 1996; 31(9):706-11. PubMed ID: 9863236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs.
    Zhang X; Yi Y; Qi J; Lu Y; Tian Z; Xie Y; Yuan H; Wu W
    Int J Pharm; 2013 Aug; 452(1-2):233-40. PubMed ID: 23688622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man.
    Leucuţa SE
    J Microencapsul; 1990; 7(2):209-17. PubMed ID: 2329447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of extended release dosage forms using non-uniform drug distribution techniques.
    Huang KK; Wang DP; Meng CL
    Drug Dev Ind Pharm; 2002 May; 28(5):593-9. PubMed ID: 12098848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preperation of terbutaline sulphate pulsatile release tablet and mechanism elucidation].
    Zhang Y; Zhang ZR
    Yao Xue Xue Bao; 2003 Nov; 38(11):854-8. PubMed ID: 14992001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
    Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):309-14. PubMed ID: 10890580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine.
    Royce A; Li S; Weaver M; Shah U
    J Control Release; 2004 May; 97(1):79-90. PubMed ID: 15147806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.